Edit |   |
---|---|
Antigenic Specificity | CD19 + CD64 (bispecific) |
Clone | monoclonal |
Host Species | Recombinant Human |
Reactive Species | human |
Isotype | n/a |
Format | bispecific |
Size | n/a |
Concentration | n/a |
Applications | FuncS; Promising therapeutic agent; |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Recombinant Human Anti-CD19 x Anti-CD64 Bispecific Antibody (CrossMab). Recombinant Anti-CD19 x Anti-CD64 Bispecific Antibody (CrossMab) is designed to be expressed as four chains with knobs-into-holes mutations and domain crossover. After one or multi-steps purification, high-purity antibody can be obtained. This BsAb can retarget neutrophils to tumor cells. It is designed for the research of B cell lymphoma; Leukemia therapy. |
Immunogen | n/a |
Other Names | CD19; CD19 molecule; Cluster of differentiation 19; B4; CVID3; B-lymphocyte antigen CD19; differentiation antigen CD19; T-cell surface antigen Leu-12; B-lymphocyte surface antigen B4 |
Gene, Accession # | UniProt: P15391 |
Catalog # | CROSSAB-H219 |
Price | please inquire |
Order / More Info | CD19 + CD64 (bispecific) Antibody from CREATIVE BIOLABS, INC. |
Product Specific References | n/a |